Skip to content

Study on Dosage Measurement of Anesthetics in Painless Upper Gastrointestinal Endoscopy in Children

Study on Dosage Measurement of Anesthetics in Painless Upper Gastrointestinal Endoscopy in Children

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041460
Enrollment
Unknown
Registered
2020-12-26
Start date
2021-01-15
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive tract disease

Interventions

Esketamine Group A:Esketamine 0mg/kg + propofol
Esketamine Group B:Esketamine 0.25mg/kg + propofol
Esketamine Group C:Esketamine 0.5mg/kg + propofol
Esketamine Group D:Esketamine 1mg/kg + propofol

Sponsors

Shanghai Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged 3~12 years; 2) Due to dyspepsia, gastric ulcer, or other diseases (such as varicose veins, ingestion of foreign bodies and corrosive esophagitis, etc.) need to undergo upper gastrointestinal endoscopy; 3) ASA score is I or II.

Exclusion criteria

Exclusion criteria: 1) Patients with contraindications to general anesthesia; 2) Patients who are tolerant or allergic to esketamine hydrochloride or propofol; 3) Children who are prescribed medications before anesthesia; 4) Past coagulation abnormalities and bleeding tendency; 5) Abnormal liver or kidney function or history of liver or kidney disease; 6) The investigator considers it inappropriate to participate; 7) The child or parents refuse.

Design outcomes

Primary

MeasureTime frame
Reaction when entering the endoscope;

Countries

China

Contacts

Public ContactYang Shen

Shanghai Children's Medical Center

yingsun821@163.com+86 18201806327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026